亚洲免费av电影一区二区三区,日韩爱爱视频,51精品视频一区二区三区,91视频爱爱,日韩欧美在线播放视频,中文字幕少妇AV,亚洲电影中文字幕,久久久久亚洲av成人网址,久久综合视频网站,国产在线不卡免费播放

        ?

        Adaptive radiation therapy of breast cancer by repeated imaging during irradiation

        2020-06-15 06:29:16OmerSagerFerratDincoglanSelcukDemiralBoraUysalHakanGamsizFatihOzcanOnurhanColakYeldaElcimEsinGundemBaharDiricanMuratBeyzadeoglu
        World Journal of Radiology 2020年5期

        Omer Sager,Ferrat Dincoglan,Selcuk Demiral,Bora Uysal,Hakan Gamsiz,Fatih Ozcan,Onurhan Colak,Yelda Elcim,Esin Gundem,Bahar Dirican,Murat Beyzadeoglu

        Abstract

        Key words: Breast cancer;Adaptive radiation therapy;Tumor bed boost;Computed tomography;Imaging;Replanning

        INTRODUCTION

        Breast cancer is the most frequent cancer among females and also a leading cause of cancer related mortality worldwide. A multimodality treatment approach may be utilized for optimal management of patients with combinations of surgery,radiation therapy (RT) and systemic treatment. RT composes an integral part of breast conserving treatment (BCT),and is typically used after breast conserving surgery(BCS) to improve local control. Recent years have witnessed significant improvements in the discipline of radiation oncology which allow for more focused and precise treatment delivery. Adaptive radiation therapy (ART) is among the most important RT techniques which may be utilized for redesigning of treatment plans to account for dynamic changes in tumor size and anatomy during the course of irradiation. In the context of breast cancer,ART may serve as an excellent tool for patients receiving breast irradiation followed by a sequential boost to the tumor bed. Primary benefits of ART include more precise boost localization and potential for improved normal tissue sparing with adapted boost target volumes particularly in the setting of seroma reduction during the course of irradiation. Herein,we provide a concise review of ART for breast cancer in light of the literature.

        MASTECTOMY AND BREAST CONSERVING TREATMENT FOR BREAST CANCER MANAGEMENT

        Both mastectomy and BCT are widely used therapeutic options for management of patients suffering from breast cancer. Selection of surgical modality as BCS or mastectomy is based on several factors including patient and tumor characteristics,assessment of outcomes in terms of cosmesis,treatment morbidity and local control,and patient preferences. In terms of efficacy,BCT and mastectomy provide comparable results which have been supported by data from randomized trials and collaborative group studies. In this context,BCT has been alternatively used for management of patients with breast cancer. Recent studies also support the utility of BCS and RT as a viable alternative to mastectomy with encouraging results.

        UTILITY OF RADIATION THERAPY AS PART OF BREAST CONSERVING TREATMENT

        Use of RT as part of BCT is increasing in line with accumulating evidence and improvements in the discipline of radiation oncology including sophisticated delivery techniques and modernized treatment equipment. Although omission of RT after BCS may be considered for a very highly selected subgroup of patients given the relatively lower local recurrence rates after BCS and endocrine treatment,RT is widely recognized as an integral part of BCT particularly to decrease the rates of local recurrence.

        CONVENTIONALLY FRACTIONATED RADIATION THERAPY OF THE INTACT BREAST: TO BOOST OR NOT TO BOOST

        Irradiation of the intact breast with conventionally fractionated RT as part of BCT typically includes whole breast irradiation (WBI) followed by a sequential tumor bed boost directed at the lumpectomy cavity. Main rationale of adjuvant RT following BCS is reduction of local recurrence. Utility of RT for breast cancer management has been assessed in a comprehensive metaanalysis. This metaanalysis reported a substantial reduction in the 10-year first recurrence rate from 35% to 19.3%,and incorporation of adjuvant RT also resulted in a breast cancer survival gain of 3.8% at 15 years,suggesting substantial benefit of adding RT after surgical management.Since local recurrence comprises a critical pattern of recurrence for breast cancer patients affecting prognosis,achieving durable local control rates is a pertinent goal of management. Given the tendency of breast tumors to recur primarily at the original tumor site,delivery of a boost RT dose to the lumpectomy cavity has been utilized for achieving improved local control rates. Rationale for boost RT includes elimination of microscopic tumor cells located at the primary tumor site to improve local control. Delivery of boost dose to the lumpectomy cavity may be performed by use of several techniques including external photon beams,external electron beams,and brachytherapy.

        DEFINITION OF THE BOOST TARGET VOLUME

        Definition of the boost target volume is a critical component of breast cancer RT.Surgical scar and clips,ultrasonography,mammography,Computerized Tomography(CT),Magnetic Resonance Imaging (MRI),clinical examination findings may be incorporated for determining the localization of tumor bed boost. However,there is no consensus on this critical issue with wide variations among clinical practices worldwide. Clearly,all methods have their advantages and drawbacks which renders a complementary or integrative approach more feasible to achieve precise target volume localization.

        THE CONCEPT OF ADAPTIVE RADIATION THERAPY

        ART refers to redesigning of treatment plans with respect to dynamic changes in tumor size and anatomy during the course of irradiation. There have been several applications of ART for a variety of indications including breast cancer,head and neck cancers,prostate cancer,and several other cancers throughout the human body.Primary objective of ART is achieving an improved therapeutic ratio. Accounting for volumetric and anatomical changes during the course of irradiation has great potential for improving treatment outcomes. This pertinent goal of RT may be achieved by incorporating smaller boost target volumes when substantial reduction in tumor burden is confirmed on periodical imaging during the RT course. Indeed,this rationale has been tested in the setting of RT after induction chemotherapy for limited-stage small cell lung cancer. The authors concluded that irradiation of the postchemotherapy volumes instead of baseline prechemotherapy volumes did not decrease locoregional control. While chemotherapy may confer substantial shrinkage of tumor volumes particularly for chemosensitive cancers,RT may also achieve reduction in tumor burden which may be exploited by use of ART techniques.Besides tumor shrinkage,replanning for boost RT may provide additional advantages for precise target localization accounting for the potential changes in patient anatomy due to weight loss or edema.

        ADAPTIVE RADIATION THERAPY OF THE INTACT BREAST BY REPEATED IMAGING DURING THE COURSE OF IRRADIATION

        For breast cancer patients receiving conventionally fractionated RT over 5-6 wk followed by a sequential tumor bed boost,ART may be utilized for more precisely focused boost RT. Replanning for the tumor bed boost may prevent excessive normal tissue exposure particularly for patients having seroma at the initiation of WBI.Several studies have reported on volumetric changes in the lumpectomy cavity during te course of breast irradiation. Data from selected studies incorporating ART for breast cancer by use of repeated imaging during the course of breast irradiation are summarized in Table 1.

        A consistent finding of the aforementioned studies is the dynamic nature of the tumor bed during the course of breast irradiation. In this context,ART may be exploited to optimize normal tissue sparing particularly in the presence of substantial seroma reduction during RT by using reduced boost target volumes. Another potential benefit of repeated imaging may be avoidance of boost localization inaccuracies due to dynamic changes during the course of breast irradiation which may allow for improved precision in boost RT. These potential benefits of ART should be considered thoroughly for management of patients with breast cancer to achieve an improved therapeutic ratio. Figure 1 shows axial CT images of a patient acquired at initial CT-simulation (on the left) for WBI planning and repeated CT-simulation (on the right) for tumor bed boost planning.

        CONCLUSION

        ART with repeated imaging during the course of irradiation may serve as an excellent tool for patients receiving breast RT followed by a sequential boost to the tumor bed.Utility of ART with widely accepted hypofractionated breast irradiation protocols,frequency of imaging for treatment plan adaptation,selection of patients for ART or routinization of the technique for every patient are areas of active investigation. There is accumulating evidence supporting the utility of ART for breast cancer management,however,future trials are needed for validation of dosimetric and clinical results of ART with repeated imaging at different time points during the course of breast irradiation.

        Table1 Selected studies incorporating adaptive radiation therapy for breast cancer by use of repeated imaging during the course of breast irradiation

        Figure1 Axial computed tomography images.

        国产精品成人av电影不卡| 自愉自愉产区二十四区| 天天看片视频免费观看| 日韩精品成人无码AV片| 久久久国产精品三级av| 人妻少妇偷人精品久久性色av| 曰韩人妻无码一区二区三区综合部| 国模私拍福利一区二区| 亚洲av影片一区二区三区 | 国产aⅴ夜夜欢一区二区三区| 成人偷拍自拍在线视频| 一区二区三区人妻av| 免费1级做爰片1000部视频| 久久综合色鬼| 国内精品嫩模av私拍在线观看 | 日日摸夜夜添夜夜添无码免费视频 | 午夜国产视频一区二区三区| 亚瑟国产精品久久| 亚洲AV无码专区一级婬片毛片| 黄片午夜免费观看视频国产| 青青草精品在线视频观看| 无码人妻久久一区二区三区不卡| 日韩欧美在线播放视频| 亚洲国产日韩综合天堂| 国产精品久久久亚洲| 人妻aⅴ无码一区二区三区| 久久亚洲精品成人AV无码网址| 日本一区二区国产精品| 亚洲七久久之综合七久久| 久久久久亚洲精品美女| 日韩国产一区二区三区在线观看 | 国产欧美一区二区精品仙草咪| 97久久综合区小说区图片专区| 少妇被粗大的猛进69视频| 国产美女精品视频线免费播放软件 | 久久久2019精品视频中文字幕| 国产三级国产精品国产专区50| 最新系列国产专区|亚洲国产| 亚洲AV秘 无码二区在线| 一区二区三区四区国产亚洲| 无码无套少妇毛多18pxxxx|